Training future researchers in rare genetic disorders affecting the brain
Predoctoral Preparatory Program (P3) in Translational Research
['FUNDING_OTHER'] · CHILDREN'S HOSP OF PHILADELPHIA · NIH-11077757
This program is all about teaching and training new research coordinators to help find better treatments for rare genetic disorders called leukodystrophies, which affect how the brain develops, so they can make a real difference in this important field.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CHILDREN'S HOSP OF PHILADELPHIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-11077757 on ClinicalTrials.gov |
What this research studies
This program aims to educate and train junior research coordinators in the field of rare genetic disorders known as leukodystrophies, which impact brain myelin development. By providing formal education and hands-on experience, the initiative seeks to inspire a new generation of researchers dedicated to advancing treatments for these conditions. Participants will engage with a network of leading academic institutions and gain exposure to translational research, enhancing their career prospects in rare disease research. The program is designed to foster long-term commitment to this critical area of medicine.
Who could benefit from this research
Good fit: Ideal candidates for this research are young scholars or early-career professionals interested in pursuing a career in rare disease research.
Not a fit: Patients who are not interested in research careers or who are already established in their research paths may not benefit from this program.
Why it matters
Potential benefit: If successful, this research could lead to a stronger pipeline of researchers focused on developing therapies for rare genetic disorders, ultimately improving patient outcomes.
How similar studies have performed: Other initiatives have successfully trained researchers in specialized fields, indicating that this approach has potential for success.
Where this research is happening
PHILADELPHIA, UNITED STATES
- CHILDREN'S HOSP OF PHILADELPHIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ADANG, LAURA ANN — CHILDREN'S HOSP OF PHILADELPHIA
- Study coordinator: ADANG, LAURA ANN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Addison disease-cerebral sclerosis syndrome, Addison disease-spastic paraplegia syndrome, Addison-Schilder syndrome, adrenocortical atrophy-cerebral sclerosis syndrome, Arylsulfatase A Deficiency Disease